Analysis of Insider Selling and Analyst Optimism at Relay Therapeutics
Thomas Catinazzo, CFO of Relay Therapeutics, Inc., sold a reported value of $227,840 worth of common stock. This transaction occurred against a backdrop of significant analyst optimism regarding the company's oncology pipeline and drug developments. The analysis highlights both the insider activity and the positive professional sentiment surroundin…